SARS-CoV-2 mRNA vaccination elicits robust and persistent T follicular helper cell response in humans

Philip A. Mudd(Washington University in St. Louis), Ali H. Ellebedy(Washington University in St. Louis), Katherine Kedzierska(Infectious Disease Research Institute), Sharlene A. Teefey(Mallinckrodt (United States)), Jane A. O’Halloran(St. Vincent's University Hospital), Wooseob Kim(Korea University), Jan Petersen(Australian Regenerative Medicine Institute), Alem Haile(Washington University in St. Louis), Thi H. O. Nguyen(The University of Melbourne), Anastasia A. Minervina(St. Jude Children's Research Hospital), Allison M. Kirk(St. Jude Children's Research Hospital), Tingting Lei(Washington University in St. Louis), Jeremy Chase Crawford(St. Jude Children's Research Hospital), Rachel M. Presti(Johns Hopkins University), Aaron J. Schmitz(Washington University in St. Louis), William D. Middleton(Mallinckrodt (United States)), Louise C. Rowntree(Peter Doherty Institute), Elizaveta Kalaidina(Washington University in St. Louis), Jackson S. Turner(Washington University in St. Louis), Mikhail V. Pogorelyy(St. Jude Children's Research Hospital), Elisa Rosati(Christian-Albrechts-Universität zu Kiel), Robert C. Mettelman(St. Jude Children's Research Hospital), Michael K. Klebert(Washington University in St. Louis), Joshua Wolf(St. Jude Children's Research Hospital), Teresa Suessen(Mallinckrodt (United States)), Jamie Rossjohn(St. Jude Children's Research Hospital), Paul G. Thomas(St. Jude Children's Research Hospital)
bioRxiv (Cold Spring Harbor Laboratory)
September 8, 2021
Cited by 52


Related Papers